| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 3.42B | 1.15B | 1.06B | 951.12M | 864.50M | 764.77M |
| Gross Profit | 1.11B | 375.02M | 339.88M | 299.74M | 269.85M | 226.24M |
| EBITDA | 357.49M | 120.61M | 106.56M | 83.14M | 80.70M | 57.18M |
| Net Income | 217.00M | 73.60M | 62.52M | 46.02M | 45.13M | 33.13M |
Balance Sheet | ||||||
| Total Assets | 1.42B | 1.41B | 1.02B | 937.99M | 947.59M | 892.58M |
| Cash, Cash Equivalents and Short-Term Investments | 101.92M | 98.91M | 64.79M | 79.96M | 168.90M | 145.08M |
| Total Debt | 202.49M | 273.13M | 175.18M | 178.05M | 263.55M | 239.67M |
| Total Liabilities | 372.96M | 442.14M | 317.73M | 304.45M | 373.24M | 373.91M |
| Stockholders Equity | 1.05B | 970.49M | 706.69M | 633.54M | 574.34M | 518.68M |
Cash Flow | ||||||
| Free Cash Flow | 297.87M | 110.38M | 102.79M | 96.81M | 34.84M | 102.58M |
| Operating Cash Flow | 308.94M | 116.43M | 112.25M | 105.11M | 39.49M | 109.41M |
| Investing Cash Flow | -799.38M | -354.61M | -119.24M | -106.59M | -42.02M | -214.24M |
| Financing Cash Flow | 270.05M | 272.30M | -8.18M | -87.45M | 26.34M | 138.19M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | $927.11M | 35.43 | 10.87% | ― | 29.89% | 10.33% | |
74 Outperform | $2.23B | 25.88 | 8.58% | ― | 18.77% | 6.88% | |
72 Outperform | $2.13B | 21.16 | 9.94% | 1.97% | 23.74% | -18.99% | |
56 Neutral | $1.16B | 121.32 | 1.29% | ― | 68.17% | -85.42% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
41 Neutral | $275.41M | ― | -73.31% | ― | 5.21% | 5.21% |
Addus HomeCare Corporation, a prominent provider of home care services, operates primarily in the personal care, hospice, and home health sectors, catering to individuals at risk of hospitalization or institutionalization. In its latest earnings report, Addus HomeCare announced a robust financial performance for the third quarter of 2025, highlighted by a 25% increase in net service revenues to $362.3 million and a net income of $22.8 million. The company also reported a significant rise in adjusted EBITDA by 31.6% year-over-year, reaching $45.1 million, and completed the acquisition of Del Cielo Home Care Services, further expanding its operations in Texas. Key drivers of growth included strong performance in the personal care segment, which accounted for 76.1% of revenues, and a notable 19% organic revenue growth in the hospice care segment. The acquisition of Del Cielo is expected to enhance Addus’s market presence in Texas, complementing previous acquisitions and supporting strategic growth initiatives. Looking forward, Addus HomeCare remains optimistic about its growth prospects, leveraging strong organic growth and strategic acquisitions to expand its market coverage and enhance shareholder value.
Addus HomeCare Corporation’s latest earnings call revealed a generally positive sentiment, marked by strong revenue growth and successful expansion through strategic acquisitions. The company’s personal care segment showed significant promise, although challenges persist in the home health sector, particularly due to potential Medicare payment cuts and hiring difficulties in urban areas. Nevertheless, the positive momentum in personal care and strategic acquisitions indicate future growth potential.
On November 3, 2025, Addus HomeCare Corporation announced its financial results for the third quarter of 2025, showing a 25.0% increase in net service revenues to $362.3 million and a 31.6% rise in adjusted EBITDA to $45.1 million compared to the same period in 2024. The company completed the acquisition of Del Cielo Home Care Services on October 1, 2025, expanding its personal care operations in Texas, which is expected to positively impact its financial results and market coverage.
The most recent analyst rating on (ADUS) stock is a Buy with a $132.00 price target. To see the full list of analyst forecasts on Addus Homecare stock, see the ADUS Stock Forecast page.